Tuberculosis (TB) is a chronic infectious disease caused by Mycobacterium tuberculosis
(Mtb), and its incidence and mortality are increasing. The BCG vaccine was developed in the …

The PE_PGRS proteins have coevolved with the antigenic ESX‐V secretory system and are
abundant in pathogenic Mycobacterium. Only a few PE_PGRS proteins have been …

Abstract Mycobacteria, including Mycobacterium tuberculosis (Mtb) and non-tuberculous
mycobacteria (NTM), pose challenges in treatment due to their increased resistance to …

Tuberculosis (TB) remains one of the most afflictive bacterial infections globally. In high
burden TB countries, surveillance, diagnosis and treatment of drug resistant TB (RR and …

Mitochondria are the powerhouse of the cell and a critical cell signalling hub that decides
the fate of the cell. Mycobacterium tuberculosis (Mtb) being a successful pathogen targets …

Abstract Inhibition of Reactive Oxygen Species (ROS) is one of the strategies that
Mycobacterium tuberculosis (Mtb) employs as its defence mechanism. In this study, the role …

Mycobacterium tuberculosis (Mtb) is the causative agent of tuberculosis (TB), a prevalent
infectious disease affecting populations worldwide. A classic trait of TB pathology is the …

Background The pathogen responsible for tuberculosis is called Mycobacterium
tuberculosis. Its interaction with macrophages has a significant impact on the onset and …

The PE and PPE family proteins of Mycobacterium tuberculosis (Mtb) is exclusively found in
pathogenic Mycobacterium species, comprising approximately 8-10% of the Mtb genome …

Tuberculosis (TB) is a fatal infectious disease that continues to pose a serious public health
threat. The emergence of drug‐resistant TB has further worsened the burden of the disease …